Comparison of Bone Changes between Neonatally Monosodium Glutamate-Treated Rats and Mini Rats

Growth hormone (GH) plays an important role in longitudinal bone growth, and hypophysectomized rats or mutant rats exhibiting dwarfism have generally been used as a GH-deficient model for humans. There also has been a GH deficient model produced by subcutaneous administration to neonatal rats with monosodium glutamate (MSG), followed by destroying GH releasing hormone (GHRH) neurons in the hypothalamic arcuate nucleus, leading to a reduction of GHRH release and a resultant reduction of GH. Recently, Mini rats, a Wistar-derived transgenic rat strain harboring a rat GH antisense gene and showing 40% lower plasma GH levels than Wistar rats, have been developed. In a previous study, Mini rats showed a smaller femur size with lower mineral density and a reduction of the metaphyseal and diaphyseal bone mass. In the present study, neonates of Wistar rats were treated subcutaneously with MSG to obtain GH-deficient rats (MSG rats), and their bones were examined and compared with age-matched MSG-untreated Wistar rats and Mini rats. Compared with the Wistar rats, body weights of the MSG rats were comparable, whereas those of the Mini rats were significantly lower. Bone size, bone mineral content and mineral density were significantly lower in the MSG rats and Mini rats than those in the Wistar rats. Histologically, the amounts of the metaphyseal cancellous bone mass and diaphyseal cortical bone mass were less in the MSG rats and much less in the Mini rats. Compared with the Wistar rats, the growth plate width and longitudinal growth rate were similarly lower. However, there were no differences in bone surface-referent parameters in the secondary spongiosa for histomorphometry among the MSG rats, Wistar rats, and Mini rats, indicating that GH may not influence bone remodeling. Thus, Mini rats are considered to be a useful model for clarifying features of GH-deficiency and examining the effects of various treatments on the bone without any specific surgery or drug administration.

[1]  J. Hopper,et al.  The Effects of Gonadectomy on Bone Size, Mass, and Volumetric Density in Growing Rats Are Gender‐, Site‐, and Growth Hormone–Specific , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  S. Manabe,et al.  Comparative Bone Morphometry between Mini Rats and Wistar Rats , 1999 .

[3]  S. Manabe,et al.  Effects of Neonatal Administration of Monosodium Glutamate on Bone in Rats , 1998 .

[4]  S. Manabe,et al.  Comparison of Age-Related Bone Changes between Mini Rats and Wistar Rats , 1998 .

[5]  J. Aloia,et al.  Histologic evidence: Growth hormone completely prevents reduction in cortical bone gain and partially prevents cancellous osteopenia in the tibia of hypophysectomized rats , 1997, The Anatomical record.

[6]  L. Lippiello,et al.  Growth hormone-releasing hormone depletion in the female rat: similarities to aging. , 1996, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7]  M. Orth,et al.  Cortical bone growth and maturational changes in dwarf rats induced by recombinant human growth hormone. , 1996, The American journal of physiology.

[8]  L. Mosekilde,et al.  Short‐term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: A dose response study , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  A. Flyvbjerg,et al.  Growth hormone stimulates bone formation and strength of cortical bone in aged rats , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  J. Aloia,et al.  Skeletal alterations in hypophysectomized rats: II. A histomorphometric study on tibial cortical bone , 1995, The Anatomical record.

[11]  B. Hollis,et al.  Effect of growth hormone on bone: Bone mineral density, trabecular bone volume, and alkaline phosphatase improve or are restored in the dwarf rat treated with growth hormone , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  N. Nakagata,et al.  Evaluation of an antisense RNA transgene for inhibiting growth hormone gene expression in transgenic rats. , 1995, Developmental genetics.

[13]  L. Lippiello,et al.  Is Glutamate-Induced Reduction in Growth Hormone-Releasing Hormone a Neuroendocrine Model of Aging in the Rat? , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[14]  C. Ohlsson,et al.  Endocrine regulation of longitudinal bone growth , 1993, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[15]  C. Farquharson,et al.  Studies on growth plate chondrocytes in situ: cell proliferation and differentiation , 1993, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[16]  A. Iritani,et al.  Growth retardation in rats whose growth hormone gene expression was suppressed by antisense RNA transgene , 1993, Molecular reproduction and development.

[17]  M. Slootweg,et al.  Growth Hormone and Bone , 1993, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[18]  J J Anderson,et al.  Effects of weight and body mass index on bone mineral density in men and women: The framingham study , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  S. Mohan,et al.  Growth hormone stimulates cortical bone formation in immature hypophysectomized rats. , 1992, Endocrine research.

[20]  J. Martin,et al.  Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats. , 1991, Endocrinology.

[21]  R. Clark,et al.  Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I. , 1989, Endocrinology.

[22]  B. Bloch,et al.  Growth hormone-deficient dwarfism in the rat: a new mutation. , 1988, The Journal of endocrinology.

[23]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  W. Millard,et al.  Growth hormone secretion in genetic large (LL) and small (SS) rats. , 1986, Endocrinology.

[25]  C. Nemeroff,et al.  Models of neuroendocrine regulation: use of monosodium glutamate as an investigational tool. , 1978, Developmental neuroscience.

[26]  J. Martin,et al.  Evidence of GH deficiency in the Munich-Wistar rat. , 1974, Endocrinology.